McKesson Corporation
No price chart data available for 1D timeframe.
Rating
Why Price Moved
Shares are trading higher after Jim Cramer highlig...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organize...
Latest News
3 days ago · zacks.com
Stay Ahead of the Game With McKesson (MCK) Q2 Earnings: Wall Street's Insights on Key MetricsBesides Wall Street's top-and-bottom-line estimates for McKesson (MCK), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended September 2026.
5 days ago · zacks.com
McKesson (MCK) Earnings Expected to Grow: Should You Buy?McKesson (MCK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 days ago · zacks.com
McKesson (MCK) Stock Dips While Market Gains: Key FactsIn the most recent trading session, McKesson (MCK) closed at $967.02, indicating a -2.6% shift from the previous trading day.
6 days ago · zacks.com
Here's Why McKesson (MCK) is a Strong Momentum StockWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
11 days ago · seekingalpha.com
McKesson: AI And FDA Overhaul Likely To Overtake Regulatory Drag In 2027McKesson Corp. stands out as an asset-heavy distributor poised to benefit from AI-driven prescription automation and expedited FDA rare-disease drug approvals. MCK's specialty and oncology segment, with 41% YoY profit growth and superior margins, insulates it from AI disintermediation risks affecting vertically integrated telehealth peers. Despite materially faster EPS growth (24% forward GAAP), MCK trades at only a modest premium (forward P/E 25.75x), with a PEG ratio of 0.55x, suggesting undervaluation.
12 days ago · zacks.com
Is Trending Stock McKesson Corporation (MCK) a Buy Now?Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
13 days ago · zacks.com
McKesson (MCK) Outperforms Broader Market: What You Need to KnowIn the latest trading session, McKesson (MCK) closed at $1, marking a +1.95% move from the previous day.
18 days ago · benzinga.com
Jim Cramer: This Health Care Stock Is A ‘Winner', X-Energy Is ‘Losing Too Much Money'On CNBC's “Mad Money Lightning Round,” Jim Cramer said McKesson Corporation (NYSE:MCK) is a “winner” and it will go much higher. “It is exactly what you buy in this environment," he added.
19 days ago · zacks.com
McKesson (MCK) Ascends While Market Falls: Some Facts to NoteMcKesson (MCK) reached $976.57 at the closing of the latest trading day, reflecting a +1.53% change compared to its last close.
20 days ago · zacks.com
McKesson (MCK) is a Top-Ranked Value Stock: Should You Buy?Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove MCK